Faricimab, CAS [[1607793-29-2]]

Produktübersicht

• Artikelname: Faricimab, CAS [[1607793-29-2]]
• Artikelnummer: TGM-T78253
• Hersteller Artikelnummer: T78253
• Alternativnummer: TGM-T78253-1MG,TGM-T78253-5MG,TGM-T78253-10MG,TGM-T78253-25MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: RG-7716 , RG7716

Produktbeschreibung

Faricimab, a bispecific antibody targeting Angiopoietin-2 (Ang-2) and VEGF-A. Faricimab prevents retinal ischemia/reperfusion (I/R) injury and vascular leakage, cell death, and inflammation in sCNV mouse models, showing superior visual acuity improvement over ranibizumab for retinal diseases including w-AMD, DME, and RVO.

Produkteigenschaften

• Reinheit: >95%
• CAS Nummer: [1607793-29-2]
• Target-Kategorie: RAAS|||VEGFR